Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine disbalance in common human cancers
Zoran Čulig
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2010) Vol. 1813, Iss. 2, pp. 308-314
Closed Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

The vanilloid capsaicin induces IL-6 secretion in prostate PC-3 cancer cells
Sophie Malagarie‐Cazenave, Nuria Olea‐Herrero, Diana Vara‐Ciruelos, et al.
Cytokine (2011) Vol. 54, Iss. 3, pp. 330-337
Closed Access | Times Cited: 54
Interaction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck Cancers
Miné Tezal
International Journal of Otolaryngology (2012) Vol. 2012, pp. 1-9
Open Access | Times Cited: 51
Targeting the Tumor Stroma as a Novel Therapeutic Approach for Prostate Cancer
Omar E. Franco, Simon W. Hayward
Advances in pharmacology (2012), pp. 267-313
Closed Access | Times Cited: 49
Cancer Stem Cells and Metastasis
Sushmita Nandy, Rajkumar Lakshmanaswamy
Progress in molecular biology and translational science (2017), pp. 137-176
Closed Access | Times Cited: 48
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer
Julia Hoefer, Johann Kern, Philipp Ofer, et al.
Endocrine Related Cancer (2013) Vol. 21, Iss. 2, pp. 175-187
Open Access | Times Cited: 45
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment
Huayu Tian, Jing Liu, J Chen, et al.
Oncogene (2015) Vol. 34, Iss. 45, pp. 5635-5647
Open Access | Times Cited: 45
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Benjamin L. Bryson, Damian J. Junk, Rocky Cipriano, et al.
Cell Cycle (2016) Vol. 16, Iss. 4, pp. 319-334
Open Access | Times Cited: 42
The effects of IKK-beta inhibition on early NF-kappa-B activation and transcription of downstream genes
Meghan J. Bloom, Sachit D. Saksena, George P. Swain, et al.
Cellular Signalling (2018) Vol. 55, pp. 17-25
Open Access | Times Cited: 39
Polyploid giant cancer cells, cytokines and cytomegalovirus in breast cancer progression
Sandy Haidar Ahmad, Ranim El Baba, Georges Herbein
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives
Nagalakshmi Nadiminty, Allen C. Gao
World Journal of Urology (2011) Vol. 30, Iss. 3, pp. 287-295
Closed Access | Times Cited: 46
Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
Ke‐Hung Tsui, Ying‐Ling Chang, Tsui‐Hsia Feng, et al.
Journal of Molecular Endocrinology (2012) Vol. 49, Iss. 2, pp. 153-163
Open Access | Times Cited: 46
Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical Cystectomy: preliminary results
Maria Sofra, Paola Cordiali Fei, Luana Fabrizi, et al.
Journal of Experimental & Clinical Cancer Research (2013) Vol. 32, Iss. 1
Open Access | Times Cited: 43
Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma
Ajay Francis Christopher, Mridula Gupta, Parveen Bansal
Gene (2016) Vol. 594, Iss. 1, pp. 30-40
Closed Access | Times Cited: 32
Immune Cell Types and Secreted Factors Contributing to Inflammation-to-Cancer Transition and Immune Therapy Response
Xingwei Chen, Xu Chi, Shengjun Hong, et al.
Cell Reports (2019) Vol. 26, Iss. 7, pp. 1965-1977.e4
Open Access | Times Cited: 31
Nanocarrier based approaches for targeting breast cancer stem cells
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, et al.
Artificial Cells Nanomedicine and Biotechnology (2017) Vol. 46, Iss. 5, pp. 885-898
Open Access | Times Cited: 31
The presentation and regulation of the IL-8 network in the epithelial cancer stem-like cell niche in patients with colorectal cancer
Guanglin Cui, Li Gui, Zhigang Pang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113252-113252
Open Access | Times Cited: 15
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9
Holger H.H. Erb, Regina V Langlechner, Patrizia Moser, et al.
Endocrine Related Cancer (2013) Vol. 20, Iss. 5, pp. 677-689
Open Access | Times Cited: 30
Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
Ke‐Hung Tsui, Shyi‐Wu Wang, Li‐Chuan Chung, et al.
BioMed Research International (2013) Vol. 2013, pp. 1-11
Open Access | Times Cited: 29
STAT3 Signaling in Cancer
Ioannis Gkouveris, Nikolaos G. Nikitakis, John J. Sauk
Journal of Cancer Therapy (2015) Vol. 06, Iss. 08, pp. 709-726
Open Access | Times Cited: 27
Inflammation and Cancer
Pamela Beatty, Sandra Cascio, Olivera J. Finn
(2017), pp. 37-49
Closed Access | Times Cited: 26
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
Matthew N. Svalina, Ken Kikuchi, Jinu Abraham, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 25
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer
Evan N. Cohen, Tamer M. Fouad, Bang‐Ning Lee, et al.
Breast Cancer Research and Treatment (2019) Vol. 176, Iss. 3, pp. 545-556
Open Access | Times Cited: 24
Detectability and reproducibility of plasma levels of chemokines and soluble receptors
Ilir Agalliu, Xiaonan Xue, Mary Cushman, et al.
Results in Immunology (2013) Vol. 3, pp. 79-84
Open Access | Times Cited: 25
Androgen receptor footprint on the way to prostate cancer progression
Myles C. Hodgson, Wayne A. Bowden, Irina U. Agoulnik
World Journal of Urology (2011) Vol. 30, Iss. 3, pp. 279-285
Open Access | Times Cited: 25
Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice
Xiaoling Yin, Ning Wang, Xing Wei, et al.
Cancer Letters (2012) Vol. 322, Iss. 1, pp. 92-97
Closed Access | Times Cited: 24

Scroll to top